June 2012 Women's Health

Preemptive Action: Reducing the Risk of Breast Cancer

June 14, 2012

Continuing Education

This continuing education activity addresses the factors that increase and decrease a woman's risk for breast cancer, and includes information for pharmacists to help provide evidence-based counseling on preventative measures.

Amylin Pharmaceuticals, Inc's Bydureon

June 13, 2012

Rx Product News Profile

Amylin Pharmaceuticals, Inc's Bydureon (exentatide extended-release for injectable suspension) is approved as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes.